BioWorld

CSI to test Diamondback 360° for coronary artery treatment

Cardiovascular Systems (CSI; St. Paul, Minnesota) is gaining even more headway with its Diamondback 360° System as the device is set to be evaluated in its treatment of coronary arteries. The company ...
Business Wire

First Patient in Europe Treated With Cardiovascular Systems, Inc. Diamondback 360 ® Coronary Orbital Atherectomy System

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Business Wire

Cardiovascular Systems Announces First Peripheral Arterial Disease Case Treated with New, Low-Profile, 60cm Diamondback Peripheral System

“CSI’s new 60cm, 4 French devices provide physicians with broader treatment options for challenging lesions in the lower leg,” said David L. Martin, CSI president and chief executive officer. “If left ...
Fierce Healthcare

Clinically Significant 12-Month Results from Cardiovascular Systems' Calcium 360° Study Published in Journal of Endovascular Therapy

Investor Relations, 651-259-2800orSarah Wozniak, 651-259-1636orMatt Sullivan, 612-455-1709orDave Folkens, 612-455-1741 Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company ...
TCTMD

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

Compliance 360 deg results presented by Dr. Raymond Dattilo show superior outcomes at six months for peripheral arterial disease patients treated with CSI's device. St. Paul, MN & San Francisco, CA ...
The Globe and Mail

Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery ...
MedCity News

Minnesota’s CSI raises $5M for arterial plaque-removing device

Cardiovascular Systems Inc. (CSI), based in New Brighton, Minnesota, has raised $5 million from the sale of debt, according to documents filed with the Securities and Exchange Commission. The company, ...
FierceBiotech

Cardiovascular Systems Signs Merger Agreement

November 4, 2008--Cardiovascular Systems Inc. (CSI) today announced that it has entered into a definitive merger agreement under which CSI will merge with Replidyne, Inc. (Nasdaq: RDYN) in an ...
Nasdaq

Cardiovascular Systems, Inc. Announces FDA Approval of the Coronary ViperWire Advance® With Flex Tip

U.S. Approval of the First and Only Nitinol Atherectomy Guide Wire Expands Company’s Portfolio of Products Targeting Complex Coronary Disease ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, ...
Star Tribune

CSI will sidestep IPO, merge with public start-up

Faced with a prolonged drought in the market for initial public offerings (IPOs), Cardiovascular Systems Inc. (CSI) said Tuesday that it will merge with a publicly traded biopharmaceutical start-up on ...
KSL

Cardiovascular Systems Announces First Peripheral Arterial Disease Case Treated with New, Low-Profile, 60cm Diamondback Peripheral System

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...